Effective transfection of a cis element "decoy" of the nuclear factor-κB binding site into the experimental choroidal neovascularization

Current Eye Research

Volumn 24, Issue 6, 2002, Pages 465-473

  Jo, Nobuo ^a   Ogata, Nahoko ^a   Aoki, Motokuni ^b   Otsuji, Tsuyoshi ^a   Morishita, Ryuichi ^b   Kaneda, Yasufumi ^b   Matsumura, Miyo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Choroidal neovascularization; Gene therapy; NF B; Retina

Indexed keywords

CIS ACTING ELEMENT; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE MICROSCOPY; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MACROPHAGE; NONHUMAN; PARAINFLUENZA VIRUS 1; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; SUBRETINAL NEOVASCULARIZATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BINDING SITES; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LIPOSOMES; NF-KAPPA B; RATS; RATS, INBRED BN; STEREOISOMERISM; TRANSFECTION;

EID: 0036968977     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.6.465.8600     Document Type: Article

References (52)

1. Macular photocoagulation study group. Argon laser photo-coagulation for senile macular degeneration: Results of randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.
2. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology. 1996;103:878-889.
3. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: Stability of early visual results. Ophthalmology. 1997;104:22-26.
4. Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related manular degeneration: A prospective study. Am J Ophthalmol. 1999;128:135-146.
5. Stalmans P, Leys A, Limbergen EV. External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: A review of 111 cases. Retina. 1997;17:481-492.
6. Tobe T, Takahashi K, Kishimoto N, Ohkuma H, Uyama M. Effect of human interferon-beta on reconstruction of the choriocapillaris in monkeys following laser photocoagulation. Nippon Gannka Gakkai Zassi. 1995;99:558-570.
7. Seo MS, Kwak N, Ozaki H, Yamada H, Okamoto N, Yamada E, Fabbro D, Hofmann F, Wood JM, Campochiaro PA. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of kinase inhibitor. Am J Pathol. 1999;154:1743-1753.
8. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92:10457-10461.
9. Ogata N, Otsuji T, Matsushima M, Kimoto T, Yamanaka R, Takahashi K, Wada M, Uyama M, Kaneda Y. Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-Liposome System. Curr Eye Res. 1999;18:261-269.
10. Otsuji T, Ogata N, Takahashi K, Matsushima M, Uyama M, Kaneda Y. In vivo gene transfer into choroidal neovascularization by the HVJ Liposome Method. Graefe's Arch Clin Exp Ophthalmol. 2000;238:191-199.
11. Shono T, Ono M, Izumi H, Jimi SI, Matsushima K, Okamoto T, Kohno K, Kuwano M. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol. 1996;16:4231-4239.
12. Stoltz RA, Abraham NG, Laniado-Schwartzman M. The role of NF-kappaB in the angiogenetic response of coronary microvessel endothelial cells. Proc Natl Acad Sci USA. 1996;93:2832-2837.
13. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-kappaB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA. 1993;90:10193-10197.
14. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem. 1994;269:13289-13295.
15. Bielinska A, Schivdasani RA, Zhang LQ, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990;250:997-1000.
16. Morishita R, Higaki J, Tomita N, Aoki M, Moriguchi A, Tamura K, Murakami K, Kaneda Y, Ogihara T. Role of transcriptional cis-element, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension. 1996;3:502-507.
17. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nature Med. 1997;3:894-899.
18. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (sendai virus): Reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Human Gene Ther. 1997;8:2133-2141.
19. Ogata N, Matsushima M, Takada Y, Tobe T, Takahashi K, Yi X, Yamamoto C, Yamada H, Uyama M. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res. 1996;15:1008-1018.
20. Ogata N, Yamamoto C, Miyashiro M, Yamada H, Matsushima M, Uyama M. Expression of transforming growth factor-βmRNA in experimental choroidal neovascularization. Current Eye Res. 1997;16:9-18.
21. Wada M, Ogata N, Otsuji T, Uyama M. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Current Eye Res. 1999;18:203-213.
22. Frank RN, Das A, Weber ML. A model of subretinal neovascularization in the pigmented rat. Curr Eye Res. 1989;8:239-247.
23. Tobe T, Takahashi T, Ohkuma H, Uyama M. Experimental choroidal neovascularization in the rat. Nippon Ganka Gakkai Zasshi. 1994;98:837-845.
24. Takehara T, Kurokawa T, Kitamura T et al. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest Ophthalmol Vis Sci. 1999;40:459-466.
25. Hangai M, Kaneda Y, Tanihara H, Honda Y. In vivo gene transfer into the retina mediated by a novel liposome system. Invest Ophthalmol Vis Sci. 1996;37:2678-2685.
26. Hangai M, Tanihara H, Honda Y, Kaneda Y. In vivo delivery of phosphorothioate oligonucleotides into murine retina. Arch Ophthalmol. 1998;116:342-348.
27. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wallin vivo: Enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene. 1994;149:13-19.
28. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA. 1993;90:8474-8478.
29. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Initial hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994;93:1458-1464.
30. Yoshida A, Yoshida S, Ishibashi T, Kuwano M, Inomata H. Supression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbmate in mice. Invest Ophthalmol Vis Sci. 1999;40:1624-1629.
31. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA. 1996;93:4851-4856.
32. Agrawal S. Antisense oligonucleotides as antiviral agents. Trends Biothechnol. 1992;10:152-158.
33. Baeuerle PA. The inducible transcription activator NF-kappaB: Regulation by distinct protein subunits. Biochem Biophys Acta. 1991;1072:63-80.
34. Grilli M, Chiu JJ, Leonald MJ. NF-kappaB, and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1-62.
35. Lenardo MJ, Baltimore D. NF-kappaB: A pleiotropic mediator of inducible and tissue specific gene control. Cell. 1989;58:227-229.
36. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994;94:877-884.
37. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327-2334.
38. Satriano J, Schlondorff D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′: 5′-cyclic monophosphate: Evidence for involvement of reactive oxygen species. J Clin Invest. 1994;94:1629-1636.
39. Brennan DC, Jevnikar AM, Takei F, Reubin-Kelley VE. Mesangial cell accessory functions: Mediation by intercellular adhesion molecule-1. Kidney Int. 1990;38:1039-1046.
40. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 1992;176:1583-1593.
41. Yamazaki T, Seko Y, Tamatani T, Miyasaka M, Yagita H, Okumura K, Nagai R, Yazaki Y. Expression of intercellular adhesion molecucle-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol. 1993;143:410-418.
42. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. A gene therapy strategy using a transcriptional factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA. 1995;92:5855-5859.
43. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
44. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50.
45. Jerdan JA, Pepose JS, Michels RG, Hayashi H, De Bustros S, Sebag M, Glaser BM. Proliferative vitreoretinopathy membranes: An immunohistochemical study. Ophthalmology. 1989;96:801-810.
46. Lopez PF, Grossniklaus HE, Lambert HM, Aaberg TM, Capone A Jr, Sternberg P Jr, L'Hernault N. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112;647-656.
47. Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, Matsumura M, Ogura Y, Honda Y. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891-1898.
48. Hempel SL, Monick MM, Hunninghake GW. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am J Respir Cell Mol Biol. 1996;14:170-176.
49. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Bio. 1997;17:4015-4023.
50. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998;28:197-208.
51. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 1998;158:1585-1592.
52. Neurath MF, Fuss I, Schurmann G, Pettersson S, Arnold K, Muller-Lobeck H, Strober W, Herfarth C, Buschenfelde KH. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann NY Acad Sci. 1998;859:149-159.